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Inflammatory cytokines have been proposed to
regulate epithelial homeostasis during intestinal
inflammation. We report here that interferon-g
(IFN-g) regulates the crucial homeostatic functions
of cell proliferation and apoptosis through serine-
threonine protein kinase AKT-b-catenin and Wing-
less-Int (Wnt)-b-catenin signaling pathways. Short-
term exposure of intestinal epithelial cells to IFN-g
resulted in activation of b-catenin through AKT,
followed by induction of the secreted Wnt inhibitor
Dkk1. Consequently, we observed an increase in
Dkk1-mediated apoptosis upon extended IFN-g
treatment and reduced proliferation through deple-
tion of the Wnt coreceptor LRP6. These effects
were enhanced by tumor necrosis factor-a (TNF-a),
suggesting synergism between the two cytokines.
Consistentwith these results, colitis in vivowas asso-
ciated with decreased b-catenin-T cell factor (TCF)
signaling, loss of plasma membrane-associated
LRP6, and reduced epithelial cell proliferation. Prolif-
eration was partially restored in IFN-g-deficientmice.
Thus, we propose that IFN-g regulates intestinal
epithelial homeostasis by sequential regulation of
converging b-catenin signaling pathways.
INTRODUCTION
Self-renewal of the intestinal epithelium is tightly regulated
by interacting intracellular signaling pathways, which control
stem cell proliferation and cell differentiation (Crosnier et al.,
2006). In particular, Wingless-Int (Wnt)-b-catenin signaling has
emerged as a key regulator of enterocyte proliferation and
survival, and mutations in this pathway are strongly associated
with the development of intestinal cancer (de Lau et al., 2007;
Logan and Nusse, 2004; Pinto and Clevers, 2005). Interestingly,392 Immunity 32, 392–402, March 26, 2010 ª2010 Elsevier Inc.development of colorectal cancer has also been linked to
chronic inflammatory conditions of the intestine such as ulcera-
tive colitis, which is thought to result from accumulating muta-
tions resulting from ongoing crypt hyperproliferation and tissue
repair (Feagins et al., 2009).
A key feature of such intestinal inflammation is a persistently
increased expression of mucosal cytokines, in association with
altered epithelial homeostasis, particularly as the disease prog-
resses from acute to chronic phase. Most notably, decreased
epithelial proliferation is observed in the early stages of colitis,
whereas increased crypt epithelial turnover is seen during
chronic inflammation (Renes et al., 2002; Serafini et al., 1981).
How the inflammatory milieu contributes to these opposing
effects on epithelial cell proliferation is not understood. However,
there is mounting evidence that cytokines play important roles in
regulating intestinal epithelial homeostasis during inflammation.
For example, interleukin-6 (IL-6) and IL-22 have recently been
shown to promote epithelial proliferation and carcinogenesis
through activation of signal transducer and activator of transcrip-
tion-3 (STAT3) (Grivennikov et al., 2009; Pickert et al., 2009).
Conversely, two major proinflammatory cytokines, interferon-g
(IFN-g) and tumor necrosis factor-a (TNF-a), are known to nega-
tively regulate the barrier properties and self-renewal of the
intestinal epithelium, thus modulating epithelial homeostasis
and exacerbating mucosal inflammation (Bruewer et al., 2006;
Capaldo and Nusrat, 2009; Kaiser and Polk, 1997; Ruemmele
et al., 1998).
We now report that IFN-g, in synergy with TNF-a, exerts
a biphasic effect on intestinal epithelial cell proliferation and
apoptosis, by sequential modulation of the serine-threonine
protein kinase AKT-b-catenin and Wnt-b-catenin signaling path-
ways. At the onset of inflammation, IFN-g activated b-catenin
through phosphoinositide-3 kinase (PI3K) and AKT, which in
turn facilitated the induction of the secreted Wnt antagonist
Dkk1 in the colonic mucosa. Consequently, we observed that
degradation of the Dkk1-low-density lipoprotein receptor-
related protein 6 (LRP6) ligand-receptor-complex inhibited
epithelial cell proliferation and promoted apoptosis, despite
continued AKT-b-catenin activation. Thus, the extended activa-
tion of AKT resulted in a shift from an early proproliferative to
Figure 1. Reduced Epithelial Cell Prolifera-
tion during Intestinal Inflammation Is Asso-
ciated with High Mucosal Concentrations
of Inflammatory Cytokines and Reduced
b-Catenin Signaling
(A) Whole colon cytokine concentrations in healthy
and inflamed mice (7 days of DSS treatment) were
determined with a multiplex protein array (see also
Figure S1). TNF-a and IFN-gwere among themost
highly induced cytokines after 7 days of DSS treat-
ment, whereas the anti-inflammatory IL-10 was
unchanged.
(B) Proliferation in healthy and inflamed colon
epithelium was determined by EdU incorporation
for 2 hr. Inflammation substantially reduced the
number of proliferating enterocytes per crypt.
Arrows indicate the crypt bottom in the inflamed
tissue. Scale bar represents 100 mm.
(C) Cell death in the same tissue as above was
determined by TUNEL staining. A dramatic
increase of dead epithelial cells at the crypt
surface was observed in response to DSS treat-
ment. Scale bar represents 100 mm.
(D) Whole colons from BAT-gal mice were stained
with X-gal (blue) to reveal regions of active b-cate-
nin-TCF signaling. Almost no staining was seen
after 7 days of DSS challenge. Magnified images
show highlighted areas in the proximal and distal
colon. Images are representative of three animals
per group. Scale bar represents 2 mm.
(E) Frozen sections from control animals were
stained with X-gal and then counterstained with
eosin (magenta). X-gal-positive nuclei of epithelial
cells are indicated with arrows in the magnified
panel on the right. Scale bar represents 100 mm.
(F) mRNA was isolated from whole colon tissue
and analyzed by real-time RT-PCR. Transcription
of Dkk1 and the Dkk-Wnt coreceptor LRP6 were
considerably changed during DSS colitis.
(G) Dkk1 protein levels in mucosal epithelial cells
were substantially increased after 7 days of DSS
challenge.
(H) Dkk1 concentration in serum from the peripheral blood was determined by ELISA. Protein expression was increased after DSS colitis.
Data in all graphs in this figure are represented as mean ± SEM. *p < 0.001 versus control (Student’s t test).
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Cytokines Regulate b-Catenin Signalinga delayed antiproliferative phenotype, both in tissue culture and
in an animal model of acute intestinal inflammation. These results
demonstrate that the proinflammatory cytokines IFN-g and
TNF-a are key regulators of b-catenin signaling and epithelial
homeostasis during intestinal mucosal inflammation.
RESULTS
Prolonged Intestinal Inflammation Inhibits IEC
Proliferation and Promotes Cell Death
Extended exposure of intestinal epithelial cells (IEC) to proin-
flammatory cytokines, as seen in human inflammatory bowel
disease and animal models of intestinal inflammation, dysregu-
lates epithelial homeostasis and exacerbates disease progres-
sion. To study the homeostasis of the intestinal epithelium during
inflammation in vivo, we used the murine dextran sulfate sodium
(DSS) colitis model of acute epithelial injury and mucosal inflam-
mation. We established a baseline for these studies by treating
animals with DSS for 7 days, which resulted in clinical symptomsresembling the active phase of human inflammatory bowel
disease, including bloody diarrhea, mucosal ulceration, and
extensive crypt loss. Because intestinal inflammation is associ-
ated with high mucosal concentrations of inflammatory cyto-
kines, whole colon tissue samples were screened for a panel
of 22 chemokines and cytokines known to regulate inflammation
and epithelial homeostasis (Figure 1A; Figure S1A and S1B
available online). The proinflammatory cytokines IFN-g and
TNF-a were found to be among the most highly induced media-
tors in the inflamed tissue (6.6-fold and 7.1-fold of healthy
control, respectively); in contrast, the concentration of anti-
inflammatory interleukin-10 (IL-10) was unchanged compared
to control animals at this time point. Both IFN-g and TNF-a are
known to regulate IEC proliferation and apoptosis (Kaiser and
Polk, 1997; Ruemmele et al., 1998), and we observed that after
7 days of DSS treatment, the overall number of proliferating
IEC was substantially reduced (Figure 1B). At the same time,
the number of terminal deoxynucleotidyl transferase dUTP nick
end labeling (TUNEL)-positive cells at the luminal interface wasImmunity 32, 392–402, March 26, 2010 ª2010 Elsevier Inc. 393
Figure 2. Regulation of Epithelial Cell Proliferation
and Apoptosis by Inflammatory Cytokines Is Asso-
ciated with Inhibition of Wnt Signaling
(A) Proliferation of T84 intestinal epithelial cells was
determined by EdU incorporation for 2 hr. IFN-g elicited
a biphasic response after extended treatment, which
was potentiated by TNF-a.
(B) Apoptosis of T84 cells was determined by TUNEL
staining. IFN-g and TNF-a synergistically enhanced cell
death over the observation period.
(C) Dkk1 protein expression in T84 cells was induced by
IFN-g treatment for 72 hr.
(D) Recombinant Dkk1 dose dependently induced
Caspase-3 activation in T84 cells after 72 hr.
(E) Mice were treated with recombinant Dkk1 (rDkk1)
or PBS for 16 hr, and apoptosis was determined by active
Caspase-3 staining. The graph shows results from >1000
crypts of two mice per group.
(F) IFN-g-induced apoptosis in T84 cells after 72 hr was
inhibited by cotreatment with GSK-3b inhibitor AR-
A014418 or a functional Dkk1 antibody. Apoptosis was
assessed by M30 staining. Scale bar represents 100 mm.
Data in all graphs in this figure are represented as mean ±
SEM. *p < 0.001 versus control (Student’s t test); yp < 0.01
versus IFN-g (ANOVA with Dunnett’s post-test).
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Cytokines Regulate b-Catenin Signalinggreatly increased compared to untreated control animals,
indicating massive cell death in response to DSS treatment
(Figure 1C). Because b-catenin is a keymolecule in the regulation
of intestinal homeostasis, we next examined the effect of pro-
longed inflammation on this pathway by using b-catenin-T cell
factor (TCF) reporter (BAT-gal) mice (Figure 1D). Largely uniform
X-gal staining was seen in the entire colon of unchallenged
control animals. In contrast, almost no staining was observed
in the colon of mice treated with DSS for 7 days, indicating
that b-catenin signaling is greatly reduced in the inflamed
intestine. Microscopic analysis of tissue sections confirmed
that the reporter was exclusively expressed in epithelial cells
(Figure 1E); in contrast, no X-gal staining was observed in the
submucosa and muscularis mucosa. Previous reports indicate
that the potent Wnt inhibitor Dkk1 is induced by inflammatory
cytokines and regulates inflammation in vivo (Diarra et al.,
2007; Gollob et al., 2005). We therefore measured the transcrip-
tion of Dkk1 and of the Dkk-Wnt coreceptor LRP6 by real-time394 Immunity 32, 392–402, March 26, 2010 ª2010 Elsevier Inc.RT-PCR of mRNA from colonic samples
(Figure 1F). We found that Dkk1 mRNA was
dramatically enhanced after 7 days of DSS
treatment. In contrast, LRP6 mRNA was mark-
edly downregulated in the inflamed tissue. To
confirm that Dkk1 expression was induced at
the protein level and to demonstrate the possi-
bility of Dkk1 signaling in intestinal epithelial
cells, we analyzed epithelial cell lysates from
healthy and DSS-treated mice by immunoblot
analysis and serum samples from both groups
by ELISA (Figures 1G and 1H, respectively).
Consistent with our PCR data, we found that
Dkk1 protein was substantially increased during
inflammation in both tissue and serum. Taken
together, these results suggest that inflamma-tory cytokines are associated with attenuated IEC proliferation
and increased apoptosis, which may be facilitated by inhibition
of the Wnt-b-catenin pathway during prolonged inflammation.
IFN-g and TNF-a Synergistically Regulate Proliferation
and Apoptosis of IEC In Vitro
To study the kinetics of IEC regulation by inflammatory cytokines,
we treated model intestinal epithelial T84 cells with recombinant
IFN-g and TNF-a and determined proliferation and apoptosis at
consecutive timepoints.We found that during the entire observa-
tion period (72 hr), IFN-g strongly increased the proliferation of
IEC with a peak at 24 hr, as indicated by EdU incorporation
(Figure2A). Similarly, extendedTNF-a treatment enhancedprolif-
eration, although this effect was delayed (24 hr) and not as
dramatic as with IFN-g. Interestingly, cotreatment with IFN-g
and TNF-a showed an early increase in proliferation that peaked
at 12–24 hr and a subsequent drop in the number of EdU-positive
cells at 48–72 hr. Because both proliferation and apoptosis are
Immunity
Cytokines Regulate b-Catenin Signalingrequired to maintain epithelial homeostasis, we next assessed
theeffect of inflammatory cytokines on IECapoptosis (Figure 2B).
As previously reported (Ruemmele et al., 1998), IFN-g alone
substantially increased apoptosis compared to untreated con-
trol from24 to 72 hr, as indicated by TUNEL staining. Additionally,
cotreatment with IFN-g and TNF-a showed a synergistic effect
that dramatically enhanced cell death, with increasing amounts
of TUNEL-positive cells over the entire observation period. Our
in vivo data show that Dkk1 expression is strongly enhanced
during intestinal inflammation. Thus, to investigate the role of
Dkk1 in vitro, we treated T84 cells with IFN-g and determined
Dkk1 protein levels after 72 hr (Figure 2C). In agreement with
the in vivo results, cytokine treatment strongly induced Dkk1
expression. In addition, we found that exposure of IEC to
recombinant Dkk1 (rDkk1) dose dependently induced apoptosis,
as indicated by Caspase-3 cleavage (Figure 2D; Koch et al.,
2009). To confirm the proapoptotic potential of Dkk1 in vivo,
healthy mice received a single intraperitoneal injection of rDkk1
or PBS, and the number of apoptotic IEC was determined by
cleaved (active) Caspase-3 staining after 16 hr (Figure 2E).
Consistent with the in vitro data, we observed that rDkk1
increased apoptosis in the large intestine. We therefore hypothe-
sized that IFN-g-induced apoptosis may be mediated by inhibi-
tion of Wnt-b-catenin signaling through Dkk1. Indeed, treatment
of IEC with either a functional Dkk1 antibody or an inhibitor of the
downstream effector kinase GSK-3b efficiently prevented
apoptosis of T84 cells in the presence of IFN-g (Figure 2F),
compared to untreated control. DMSO carrier and IgG isotype
controls were run separately and yielded results comparable to
no treatment control (data not shown). In summary, these results
indicate that inflammatory cytokines regulate IEC proliferation
and apoptosis through induction of Dkk1.
IFN-g and TNF-a Regulate AKT-b-Catenin
and Wnt-b-Catenin Signaling in a Temporally
Distinct Fashion
Our results suggested that inflammatory cytokines elicit
a biphasic proliferative and apoptotic response in intestinal
epithelial cells. To explore the underlying signaling pathways,
T84 cells were treated with cytokines for 5, 24, or 72 hr, and the
activity of major signaling molecules involved in Wnt and AKT
signaling were then determined by immunoblot (Figure 3A;
Figure S2A). In agreement with previous findings (Kaur et al.,
2008a), AKT was rapidly and persistently activated by IFN-g, as
shown by increased phosphorylation of AKT residue Thr308 at
all time points. This effect was facilitated through PI3K (Nguyen
et al., 2001), as indicated by the fact that there was complete
loss of IFN-g-induced AKT activation in the presence of PI3K
inhibitor LY294002 (Figure S2B). Interestingly, wheras TNF-a
alone had a limited effect on AKT activity, cotreatment with
IFN-g enhanced AKT phosphorylation at 5 hr and 72 hr of cyto-
kine exposure. Consequently, phosphorylation of b-catenin by
AKT at residue Ser552, which indicates transcriptional activation
of the protein (He et al., 2007), was increased in cells treated with
both cytokines in all experiments (Figure 3A). In contrast, phos-
phorylation of LRP6 at residue Ser1490 indicative of active Wnt
signaling (Tamai et al., 2004) was decreased as early as 24 hr in
the presence of IFN-g and TNF-a (Figure S2A). This coincided
with increased expression of Dkk1 at this time point. After72 hr, almost no LRP6 activity was observed when cells were
treated with IFN-g, and this effect was enhanced after cotreat-
ment with TNF-a. In contrast, no changes in the protein expres-
sion of the Dkk1 receptor Kremen-1 were observed in these
experiments (Figure S2A) or during inflammation in vivo (data
not shown). Because the reduction of LRP6 activity may be
caused be a loss of total protein, the effect of IFN-g treatment
in vitro and inflammation in vivo on LRP6 expression was investi-
gated by immunofluorescence microscopy (Figure 3B). LRP6
was almost completely absent from T84 cells treated with
IFN-g for 72 hr. This was mediated by Dkk1, rather than a direct
cytokine effect, as evidenced by a striking loss of LRP6 in intes-
tinal epithelial cells after 1 hr in the presence of recombinant
Dkk1but not IFN-g (FigureS2C). Likewise, little LRP6wasdetect-
able in the lateral membrane of colonic enterocytes from mice
treated with DSS for 7 days, although we observed increased
nuclear LRP6 staining consistent with endodomain shedding
(Mi and Johnson, 2007). To confirm these observations, IEC
lysates from healthy or inflamed tissue were analyzed by immu-
noblot (Figure 3C). In agreement with the data shown in
Figure 3B, LRP6 protein was virtually undetectable in animals
treated with DSS for 7 days, whereas AKT and b-catenin activity
were increased. Interestingly, although the AKT phosphorylation
target GSK-3b was more inactive in the inflamed tissue, we did
not observe substantial changes in total amounts of b-catenin
protein. Furthermore, b-catenin expression or activation did not
correlate with GSK-3b activity. These observations suggest
that although GSK-3b may be a key molecule in regulating
chronic inflammation, b-catenin protein stability is of secondary
importance at the time points investigated here. We next asked
whether loss of LRP6 is sufficient to inhibit IEC proliferation.
Indeed, downregulation of LRP6 in Caco-2 cells via siRNA
caused a substantial reduction of EdU incorporation (Figure 3D).
We additionally investigated the effect of IFN-g by a b-catenin-
TCF reporter assay (TOPflash), and we included IL-6 and IL-22,
which have been shown to regulate epithelial cell proliferation
through STAT3 (Figure 3E; Grivennikov et al., 2009; Pickert
et al., 2009). SK-CO15model intestinal epithelial cellswere trans-
fected with the reporter plasmid and treated with cytokines for
24 hr. IFN-g, but not IL-6, IL-22, or IL-10, substantially inhibited
TCF activity. TNF-a, which by itself had no discernible effect,
synergistically increased the influence of IFN-g. The effect of IL-6
and IL-22 on AKT and Wnt signaling after 24 hr was additionally
investigated by immunoblot (Figure 3F), with no apparent change
in the activity of LRP6, AKT, and b-catenin, or the expression of
Dkk1. Taken together, these data suggest that at early time
points, IFN-g and TNF-a promote IEC proliferation by activating
AKT-b-catenin signaling, but inhibit proliferation after prolonged
exposure by inhibition of Wnt-b-catenin through Dkk1 upregula-
tion. To investigate whether this temporal regulation could be
observed in vivo, mice were challenged with DSS, and epithelial
turnover on subsequent days was determined by 5-bromo-
2-deoxyuridine (BrdU) incorporation (Figure 3G; Figure S2D). We
observed a slight increase in BrdU-positive cells on days 1–3 but
an almost complete absence of proliferating enterocytes on days
4–6. Interestingly, although there was very little proliferation in
most of the epithelium at the later time points, there was an
increase in IEC proliferation on day 7 and a dramatic increase
in BrdU incorporation in crypts adjacent to mucosal ulcersImmunity 32, 392–402, March 26, 2010 ª2010 Elsevier Inc. 395
Figure 3. Inflammatory Cytokines Differen-
tially Regulate AKT andWnt Signaling Path-
ways
(A) Activity of LRP6 (phosphorylation of Ser1490),
AKT (phosphorylation of Thr308), and b-catenin
(phosphorylation of Ser552) in T84 cells was
analyzed after 5 and 72 hr. IFN-g activated AKT-
b-catenin signaling but inhibited Wnt activity.
TNF-a partially amplified this effect.
(B) Top: immunofluorescence microscopy re-
vealed a loss of LRP6 protein in T84 cells after
treatment with IFN-g for 72 hr. Scale bar repre-
sents 50 mm. Bottom: DSS challenge in vivo for
7 days resulted in a loss of LRP6 from the apical
and lateral membrane of colonic enterocytes.
Arrows highlight nuclear LRP6 staining. Scale bar
represents 20 mm.
(C) Loss of LRP6 after DSS treatment was
confirmed by immunoblot of mucosal epithelial
cells. Additionally, inflammation increased the
activity of AKT and b-catenin. Samples were taken
from two animals per group.
(D) LRP6 was targeted in Caco-2 cells with
specific siRNA. Loss of LRP6 caused a substantial
drop in cell proliferation, as indicated by EdU
incorporation for 1 hr.
(E) b-catenin transcriptional activation was
assessed with a TOPflash assay in SK-CO15
intestinal epithelial cells. Cells were treated as
indicated for 24 hr.
(F) Immunoblot analysis revealed no effect of IL-6
and IL-22 on Wnt and AKT signaling after 24 hr
of treatment. Blots are representative of three
experiments.
(G) Temporal regulation of enterocyte proliferation
duringDSScolitiswasdeterminedbyBrdU incorpo-
ration for1hr.CorrespondingH&Estainingsdemon-
strate the severity of colitis. The lowest number
of BrdU-positive epithelial cells was observed on
day 4. Images are representative of three animals
per time point. Scale bars represent 200 mm.
Data in all graphs in this figure are represented as
mean ± SEM. *p < 0.01 versus control (Student’s t
test); yp < 0.05, zp = 0.06 versus control (ANOVA
with Dunnett’s post-test). For additional informa-
tion please see also Figure S2.
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Cytokines Regulate b-Catenin Signaling(Figure S2D). We additionally investigated cell death in these
experiments byTUNEL staining (FigureS2E).NoDNA fragmenta-
tion was observed on days 0–4; in contrast, pronounced TUNEL396 Immunity 32, 392–402, March 26, 2010 ª2010 Elsevier Inc.stainingwas seen on days 5–7, coinciding
with marked histological damage illus-
trated in Figure 3G and Figure S2D. Taken
together, these data suggest that IFN-g
and TNF-a elicit a biphasic effect on IEC





To further evaluate the contribution of
AKT signaling to the increased IEC prolif-eration after short-term cytokine treatment, T84 cells were
treated with IFN-g and the AKT inhibitor triciribine for 24 hr
(Figure 4A). As can be seen, AKT inhibition dramatically
Figure 4. Epithelial Cell Proliferation and Dkk1
Expression Are Controlled by AKT
(A) T84 cell proliferation in the presence of AKT inhibitor
triciribine and IFN-gwas determined by EdU incorporation
for 2 hr after treatment for 22 hr. Inhibition of AKT signaling
attenuated IFN-g-induced proliferation. Scale bar repre-
sents 100 mm.
(B) AKT inhibition ameliorated intestinal inflammation
in vivo. The graph shows the results from three mice per
group.
(C) Immunoblot analysis of mucosal lysates showed
strongly inhibited AKT and b-catenin activity, as well as
Dkk1 expression, in mice receiving DSS and AKT inhibitor.
(D) EdU incorporation for 2 hr revealed increased crypt cell
proliferation in animals treated with triciribine. Scale bars
represent 50 mm.
Data in all graphs in this figure are represented as mean ±
SEM. yp < 0.01 versus control (ANOVA with Dunnett’s
post-test). For additional information please see also
Figure S3.
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Cytokines Regulate b-Catenin Signalingdecreased the proliferation of IEC in the absence of cytokine
compared to DMSO control and almost completely inhibited
IFN-g-induced proliferation, suggesting a critical role for AKT
signaling in intestinal epithelial homeostasis. The potency of
the AKT inhibitor, as well as its effect on b-catenin phosphoryla-
tion, was investigated by immunoblot (Figure S3A). AKT and
b-catenin phosphorylation on residues Thr308 and Ser552,
respectively, was efficiently inhibited in the presence of the
inhibitor after 4 hr, compared to DMSO control. In the same
experiment, we also observed that AKT inhibition reduced the
expression of IFN-g-induced Dkk1. Because these results
indicated that Dkk1 expression is, in part, controlled by AKT,
we investigated the effect of AKT inhibition in vivo (Figures
4B–4D). Mice receiving DSS and triciribine developed substan-
tiallymilder colitis, as indicated by reduced disease activity index
(Figure 4B) and decreased colon weight/length ratios (data not
shown). Consistent with the cell culture data, AKT inhibition
reduced AKT and b-catenin phosphorylation, and consequently,
decreased Dkk1 expression (Figure 4C). Finally, 5-ethynyl-2-
deoxyuridine (EdU) incorporation revealed strongly increased
crypt cell proliferation in animals treated with the AKT inhibitor
during DSS colitis (Figure 4D). Taken together, these in vivo
and in vitro data suggest the following model of cytokine-medi-
ated regulation of IEC proliferation and apoptosis: In the healthy
intestinal epithelium, tissue homeostasis is maintained by inte-
grated outside-to-inside signaling pathways, including the AKT
and Wnt pathway. At the onset of inflammation, exposure of
intestinal epithelial cells to inflammatory cytokines, primarily
IFN-g and TNF-a, promotes proliferation by activation of b-cate-
nin signaling through PI3K-AKT (Scoville et al., 2008). Prolonged
inflammation thus results in the induction of b-catenin-TCFImmunity 32, 3target genes, including the secreted Wnt inhib-
itor Dkk1. Consequently, the accumulation of
Dkk1 in the intestinal mucosa leads to inhibition
of Wnt-b-catenin signaling by internalization
and degradation of LRP6 (Mao et al., 2002;
Niehrs, 2006), resulting in a shift from an early
proproliferative to a delayed proapoptoticphenotype with reduced proliferation. This effect may be exacer-
bated by additional secretion of Dkk1 from nonepithelial
cells, such as infiltrating leukocytes and platelets (Figure S3B;
Voorzanger-Rousselot et al., 2009), and the inhibition of GSK-
3b by AKT. Thus, inflammatory cytokines inhibit IEC proliferation
during sustained intestinal inflammation by inhibiting the Wnt-
b-catenin signaling pathway.
Loss of IFN-g Decreases Intestinal Inflammation In Vivo
To test the model, we challenged IFN-g-deficient (Ifng/) mice
and wild-type controls with DSS for 7 days. We hypothesized
that IFN-g may exacerbate intestinal inflammation in vivo by
regulating AKT-b-catenin and Wnt-b-catenin signaling, and
conversely, loss of IFN-g may ameliorate disease progression.
We determined that in the DSS colitis model, IFN-g is primarily
secreted by CD8+ T cells and NK cells at the onset of inflamma-
tion (24 hr after challenge) (Figure S4A). Additional limited
expression of IFN-g was observed in a subset of dendritic cells
and neutrophils, consistent with previous reports (Chan et al.,
2006; Yin and Ferguson, 2009). In contrast, after 7 days of
DSS treatment, IFN-g is strongly expressed inmost lymphocytes
(Figure S4B), as shown in a recent study on viral infection of
mucosal epithelial cells (Nakanishi et al., 2009). As reported
previously (Ito et al., 2006), inflammation was substantially
decreased in Ifng/ mice, as indicated by a reduced combined
disease activity score (Figure 5A) and blinded histology scores
(Figure 5B). We hypothesized that loss of IFN-g decreases the
activity of AKT-b-catenin signaling, and consequently reduces
the induction of Dkk1 during inflammation. Indeed, DSS treat-
ment of wild-type mice for 7 days greatly increased the number
of phospho-b-catenin Ser552 staining in enterocytes (Figure 5C).92–402, March 26, 2010 ª2010 Elsevier Inc. 397
Figure 5. IFN-g-Deficient Mice Are Pro-
tected from DSS Colitis, which Coincides
with Increased Wnt Signaling and Prolifera-
tion
(A) Combined disease activity index of wild-type
and IFN-g-deficient mice (Ifng/) during DSS
colitis. Ifng/ animals showed a substantially
ameliorated course of disease over the entire
observation period.
(B) Histological scoring after 7 days of DSS chal-
lenge revealed greatly reduced severity of disease
in Ifng/ mice.
(C) Absence of IFN-g inhibited the activation of
b-catenin (phosphorylation of Ser552) after DSS
challenge, as shown by immunofluorescence
microscopy (left) and immunoblot (right).
(D) Induction of Dkk1 during inflammation was
substantially reduced in Ifng/ mice, as shown
by ELISA of serum from the peripheral blood.
(E) Immunoblot of mucosal epithelial cells from
three mice per group revealed a partial rescue of
LRP6 expression in Ifng/ mice.
(F) Immunofluorescence staining of LRP6 (green)
and Ki67 (red) revealed increased lateral mem-
brane association of LRP6 and an extension of
the proliferative crypt compartment in histologi-
cally comparable tissue from Ifng/ mice. Aster-
isks indicate the margin of mucosal ulcers.
(G) Proliferation of colonic enterocytes, as shown
by BrdU incorporation for 1 hr, was partially
rescued in Ifng/ mice after DSS treatment for
7 days.
Data in all graphs in this figure are represented as
mean ± SEM. *p < 0.01 versuswild-type (Student’s
t test). For additional information please see also
Figure S4.
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Cytokines Regulate b-Catenin SignalingIn contrast, considerably less phospho-b-catenin staining was
observed in Ifng/ mice, which was confirmed by immunoblot
analysis of epithelial cell lysates. Additionally, there were
substantially reduced concentrations of Dkk1 in the sera of
Ifng/mice compared to wild-type animals after DSS challenge
(Figure 5D). Consequently, we observed a partial rescue of LRP6
protein levels in the Ifng/ mice after 7 days of DSS treatment,
compared towild-type animals (Figure 5E). To exclude the possi-
bility that increased LRP6 protein levels might simply be the
result of decreased inflammation in Ifng/ mice, we investi-
gated LRP6 expression and IEC proliferation in histological
samples with matched disease activity (Figure 5F; Figure S4C).
LRP6 expression in the lateral membrane of enterocytes was
strongly enhanced both in acutely ulcerated areas and nonin-
flamed tissue of Ifng/ mice, compared to wild-type controls.
This coincidedwith an extension of the proliferative zone, as indi-
cated by Ki67 staining. Finally, BrdU incorporation assay after398 Immunity 32, 392–402, March 26, 2010 ª2010 Elsevier Inc.7 days of DSS treatment revealed a
partial rescue of enterocyte proliferation
in Ifng/ mice (Figure 5G) but no detect-
able difference in TUNEL-positive cells
(data not shown). Taken together, these
data suggest that loss of IFN-g protects
against intestinal inflammation by pre-
venting the activation of AKT-b-cateninsignaling and consequently the inhibition of Wnt-b-catenin by
induction of Dkk1. This conclusion was further supported by
the observation that treatment of Ifng/ mice with recombinant
Dkk1 reduced IEC proliferation and exacerbated DSS colitis
(data not shown), consistent with previous reports (Kuhnert
et al., 2004; Pinto et al., 2003). In summary, these results show
that reduced intestinal inflammation in Ifng/mice is associated
with decreased Dkk1 expression and consequently increased
IEC proliferation.
DISCUSSION
Cytokines such as IFN-g and TNF-a are critical mediators of
inflammatory disorders. We and others have previously shown
that IFN-g contributes to the epithelial barrier defect associated
with inflammatory bowel disease, by disassembling tight junc-
tions and reducing the rate of intestinal epithelial cell migration
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Cytokines Regulate b-Catenin Signaling(Gu¨nzel et al., 2006; Tong et al., 2005; Utech et al., 2005; Wang
et al., 2005). Furthermore, it is well established that both cyto-
kines regulate intestinal epithelial cell proliferation and apoptosis
in vitro and in vivo (Kaiser and Polk, 1997; Ruemmele et al., 1998;
Seno et al., 2009; Turner, 2006).
In this report, we demonstrate that IFN-g exacerbates intes-
tinal inflammation in vivo by temporally distinct regulation of
converging b-catenin signaling pathways. With cell culture and
mouse colitis models, we show that cytokine exposure leads
to an early and sustained activation of AKT-b-catenin, which
is probably initiated by phosphorylation of PI3K by IFN-g
receptor-associated Jak1 and 2 kinases (Kaur et al., 2008b;
Lekmine et al., 2004) and results in increased IEC proliferation.
This effect is mainly mediated by IFN-g, and potentiated by
TNF-a, which by itself does not appreciably affect epithelial
homeostasis. This study demonstrates that both cytokines
cooperate to promote proliferation through AKT-b-catenin,
although synergy of IFN-g of TNF-a has been reported in other
contexts, such as nuclear factor (NF)-kB signaling (Fish et al.,
1999; Ganster et al., 2005; Robinson et al., 2003; Schmitz
et al., 1999). Conversely, we observed that extended exposure
to inflammatory cytokines inhibits epithelial cell proliferation
and promotes IEC apoptosis, despite continued AKT-b-catenin
signaling. We propose that this is achieved by induction of the
Wnt inhibitor Dkk1, which is a direct transcriptional target of
b-catenin-TCF (Niida et al., 2004). Indeed, in agreement with
previous studies (Diarra et al., 2007; Gollob et al., 2005), we
observed that Dkk1 expression is dramatically upregulated
upon cytokine exposure in vitro and in vivo. Effective Wnt inhibi-
tion in epithelial cells during inflammation was indicated by an
almost complete loss of theWnt-Dkk1 coreceptor LRP6, as indi-
cated by the fact that the current model of Dkk1 signaling postu-
lates internalization and degradation of the ligand-receptor
complex (Niehrs, 2006). Accordingly, inhibition of Dkk1 in vivo
has been shown to be beneficial in inflammatory arthritis (Diarra
et al., 2007), and we observed that Dkk1 hypomorphic double-
ridge mice (MacDonald et al., 2004) are protected from DSS
colitis and demonstrate accelerated mucosal wound healing
after DSS withdrawal (unpublished data).
ActiveWnt-b-catenin signaling is required for intestinal epithe-
lial homeostasis, and aberrant Wnt signaling has been shown to
be strongly associated with the development of intestinal
cancers (Barker et al., 2009; de Lau et al., 2007). However, we
show here that prolonged cytokine exposure inhibits the Wnt
pathway and TCF-mediated gene transcription. In light of this
observation, it is interesting to note that we and others observed
that crypts adjacent to ulcers show a high rate of proliferation
(Renes et al., 2002; Seno et al., 2009), suggesting that these
‘‘hot spots’’ may be the origins of colorectal cancer seen in
long-standing inflammatory bowel disease. In this context, it is
also noteworthy that Dkk1 in the inflamed tissue may be derived
from sources other than epithelial cells, including inflammatory
macrophages (Diarra et al., 2007), platelets (Voorzanger-Rous-
selot et al., 2009), and neutrophils (Figure S3B). This suggests
that inflammatory cell infiltrates actively inhibit epithelial cells
proliferation by secretion of Dkk1. Indeed, a recent report shows
that treatment of mice with R-spondin1, an antagonist of Dkk1,
ameliorated DSS colitis, which was associated with increased
IEC proliferation (Zhao et al., 2007).Consistent with our model and a previous report (Ito et al.,
2006), IFN-g cytokine-deficient mice exhibited a less severe
progression of experimental colitis. This coincided with reduced
release of Dkk1 and higher rates of proliferation in the intestinal
epithelium. It is not surprising that such animals are not
completely protected from intestinal disease, for a number of
reasons. For example, Dkk1 may also be induced by TNF-a
(Diarra et al., 2007) or other inflammatory mediators that have
not been investigated in this study. Furthermore, other factors
contributing to disease manifestation and severity, including
tissue damage caused by invading neutrophils, may not be
affected by IFN-g. A most interesting observation is that IEC
proliferation during inflammation exhibits a multiphasic pheno-
type, with high proliferation in the beginning followed by a period
with almost no proliferation and a late recovery phase despite
continued cytokine exposure. A similar pattern of proliferation
has in fact been observed in patients with inflammatory bowel
disease, and it has been proposed that increased proliferation
during active colitis is responsible for preneoplastic lesions
(Serafini et al., 1981). We propose that these temporally discrete
changes in epithelial turnover rates are facilitated by alternating
integrated responses in b-catenin signaling. Alternatively, there
is evidence from in vitro studies showing that extended treat-
ment of intestinal epithelial cell lines with IFN-g and TNF-a can
change their response from growth arrest to high proliferation
(Seidelin et al., 2004), an effect that may be facilitated by
changes in MAP kinase signaling or cytokine receptor presenta-
tion (Kaiser et al., 1999; Pimentel-Muin˜os and Seed, 1999). Addi-
tionally, it has been proposed that cytokine secretion itself may
fluctuate over time (Nakamura et al., 1992), thereby regulating
proliferation and apoptosis during different stages of inflamma-
tion. Finally, other cytokines such as IL-6 and IL-22 have been
shown to promote intestinal epithelial cell proliferation and
carcinogenesis through STAT3 (Grivennikov et al., 2009; Pickert
et al., 2009). Although we show here that these cytokines do not
regulate b-catenin signaling, at least in the time frame of our
experiments, it is possible that during chronic colitis, crypt
hyperproliferation and remodeling are driven by both STAT and
b-catenin signaling.
In summary, we show that IFN-g and TNF-a synergistically
regulate epithelial homeostasis during intestinal inflammation,
by differential control of AKT-b-catenin and Wnt-b-catenin
signaling pathways. These observations provide new insight
into the signaling pathways governing intestinal epithelial cell
turnover and probably have important implications for the
pathology of inflammatory bowel disease and inflammation-
associated tumorigenesis.EXPERIMENTAL PROCEDURES
Antibodies and Reagents
Primary antibodies were obtained from the following sources: BD PharMingen
(CD4, CD8, CD11b, CD11c, Ly6G, NK1.1, IFN-g), Cell Signaling (LRP6,
phospho-LRP6 Ser1490, phospho-AKT Thr308), Novus Biologicals (anti-
human Dkk1), R&D Systems (anti-mouse Dkk1), Roche Pharmaceuticals
(M30), Santa Cruz (Kremen-1), and Sigma-Aldrich (Actin, Caspase-3, tubulin).
The antibody against phospho-b-catenin Ser552 was produced as described
previously (He et al., 2007). Secondary antibodies were purchased from Invi-
trogen and Jackson ImmunoResearch. The functional inhibitory Dkk1 antibody
was obtained from R&D Systems and used at a concentration of 20 mg/ml.Immunity 32, 392–402, March 26, 2010 ª2010 Elsevier Inc. 399
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Cytokines Regulate b-Catenin SignalingRecombinant mouse Dkk1 carrying the Strep-tag (Schmidt and Skerra, 2007)
was prepared by refolding of inclusion bodies expressed in E. coli, followed
by purification via streptavidin affinity chromatography and gel filtration.
Recombinant human IFN-gwas provided byGenentech and used at a concen-
tration of 100 U/ml. Recombinant human TNF-awas purchased fromBioVision
and used at a concentration of 50 ng/ml. Recombinant human IL-6, IL-10, and
IL-22 were bought from BioLegend and used at a concentration of 100 ng/ml.
LRP6 and scrambled siRNASMARTpools were obtained fromDharmacon and
transfected with TransIT siQUEST (Mirus Bio). Primers for real-time RT-PCR
were purchased from IDT (sequences are as follows: Dkk1 forward 50-TAC
AAT GAT GGC TCT CTG CAG CCT-30; Dkk1 reverse 50-GCA GGT TCT
TGA TCG CGT TGG AAT-30; LRP6 forward 50-AAG CAG TGA TCT CTC AGG
TGC CAA-30; LRP6 reverse 50-ATT CGA GCC TGG ACC TTG GTT CTT-30).
AKT inhibitor triciribine, PI3K inhibitor LY294002, and GSK-3b inhibitor
AR-A014418 were obtained from Calbiochem and used according to the
supplier’s recommendation.
Cell Culture
Intestinal epithelial T84 cells were grown in 1:1 DMEM and modified Ham’s
F-12 medium, and SK-CO15 and Caco-2 cell were grown in DMEM with
10% fetal calf serum and antibiotics. Cells were maintained in a humidified
incubator with 5% CO2. For functional studies, cells were seeded onto
collagen-coated, permeable filters (Costar) or glass coverslips.
Animal Experiments
All procedureswith animals were reviewed and approved by the Emory Univer-
sity Institutional Animal Care and Use Committee (IACUC) andwere performed
according to NIH criteria. b-catenin-TCF reporter mice (BAT-gal) (Maretto
et al., 2003), IFN-g cytokine-deficient mice, and matching control mice with
a C57Bl/6J genetic background were obtained from The Jackson Laborato-
ries. Animals were housed in a standard day and night cycle, with free access
to food and water. Experimental colitis was induced by addition of 3% wt/vol
dextran sulfate sodium (DSS; US Biologicals) to the drinking water. Disease
activity was monitored by daily assessment of a combined disease activity
index (Cooper et al., 1993). Histological specimens were analyzed in blinded
fashion by a trained surgical GI pathologist (A.N.) and scored as described
previously (Dieleman et al., 1998). Detailed information on disease activity
and histological scoring, as well as assessment of additional clinical parame-
ters from experiments with Ifng/ mice, can be found in Table S1 and Figures
S4D–S4F. Intestinal epithelial cells were isolated fromwashed colon segments
by repeated incubation with 50 mM EDTA (Sigma-Aldrich) in HBSS. mRNA
was isolated from whole colon samples by mechanical destruction of snap-
frozen tissue specimens into IsolRNA Lysis Reagent (5 Prime), followed by
phenol and chloroform extraction. Serum Dkk1 concentrations were deter-
mined by ELISA with antibodies from R&D Systems, with recombinant mouse
Dkk1 as standard. b-galactosidase expression in BAT-gal mice was visualized
by 5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-gal) staining,
essentially as described previously (Byrne et al., 1994). In brief, tissue speci-
mens were fixed with 3.7% wt/vol paraformaldehyde (PFA), incubated with
X-gal staining solution overnight, and then postfixed in PFA before further
processing. Intestinal epithelial cell apoptosis was induced by i.p. injection
of 250 mg/kg body weight recombinant mouse Dkk1, with PBS as control.
AKT was inhibited by daily i.p. injection of 2 mg/kg body weight triciribine,
with DMSO as control.
Assessment of Proliferation and Apoptosis
Proliferation was determined in vivo by intraperitoneal injection of 100 mg
5-ethynyl-2-deoxyuridine (EdU, Invitrogen) or 50 mg/kg body weight
5-bromo-2-deoxyuridine (BrdU, Sigma-Aldrich). EdU incorporation was deter-
mined with a Click-iT EdU Cell Proliferation Kit (Invitrogen), according to the
supplier’s instructions. BrdU was detected after EtOH and glycine fixation of
5 mm frozen sections of intestinal mucosa. Specimens were digested with
0.05% trypsin, and antigen was retrieved by denaturation with 4 M HCl.
Neutralized slides were then incubated with a fluorophore-labeled BrdU anti-
body (Roche Pharmaceuticals). Proliferation in vitro was assessed by EdU
incorporation. Apoptosis in vivo was determined by staining with an antibody
against cleaved (active) Caspase-3 (R&DSystems). Cell death was determined
by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL), with400 Immunity 32, 392–402, March 26, 2010 ª2010 Elsevier Inc.an In Situ Cell Death Detection Kit (Roche Pharmaceuticals), according to the
supplier’s guidelines.
Immunoblot
Samples were resuspended in Ripa lysis buffer (150 mM NaCl, 1% NP-40,
0.5% deoxycholic acid, 0.1% SDS, 50 mM Tris [pH 8.0]) containing protease
and phosphatase inhibitors (Sigma), sonicated, and cleared by centrifugation.
Protein concentration was determined with a BCA protein assay, and samples
were boiled in SDS sample buffer with 50 mM dithiothreitol. Equal amounts of
protein were separated by SDS-PAGE and transferred onto nitrocellulose
membranes. Membranes were blocked for 1 hr with 5% wt/vol dry milk or
BSA in Tris-buffered saline containing 0.1% Tween-20 and incubated with
primary antibodies in blocking buffer overnight at 4C.
Immunofluorescence Microscopy
Cells grown on coverslips or transparent filter inserts were fixed and permea-
bilized with either 100%methanol or ethanol at20C for 20min, or PFA 3.7%
wt/vol for 10 min followed by 0.5% vol/vol Triton X-100 for 5 min. Tissue
sections were fixed with PFA, then permeabilized with 100% ethanol. Samples
were then blocked with 2% wt/vol BSA for 1 hr and incubated with primary
antibodies overnight at 4C. After incubation with fluorophore-labeled
secondary antibodies for 1 hr, nuclei were stained with ToPro-3 iodide (Molec-
ular Probes), and coverslips weremounted in p-phenylene. Images were taken
on an LSM 510 confocal microscope (Zeiss) with Plan-NEOFLUAR 1003/1.3
oil, 403/1.3 oil, and 203/0.5 dry objectives, with software supplied by the
vendor.
In Vivo Cytokine Screen
Whole colon samples were homogenized into Hanks’ buffer containing 0.1%
Triton X-100, as well as protease and phosphatase inhibitors. Cytokines
were detected with a customized MILLIPLEX MAP Mouse Cytokine/Chemo-
kine Panel (Millipore), according to the supplier’s guidelines.
Statistics
Dunnett’s posttest after one-way ANOVA or two-tailed Student’s t test was
used to analyze the data. p < 0.05 was considered statistically significant.
Results are displayed as mean ± standard error of the means (SEM).
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and one table and can be
found with this article online at doi:10.1016/j.immuni.2010.03.001.
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